Clinical Trial Update: Ablation in Patients With HF and Symptomatic AF: PULVERISE-AF-CRT [NA]

View source ↗

Summary

The PULVERISE-AF-CRT trial evaluating catheter ablation in patients with heart failure and symptomatic atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• catheter ablation

Snippet

Sponsor: University Medical Center Groningen | Conditions: Atrial Fibrillation, Heart Failure | NA | Status: WITHDRAWN